\-\ Texto\\:\\ \ \(0\)\
\-\ hypertension\\.\\ seizure\\.\\ serum\\ creatinine\\ of\\ 12\\.0\\ mg\\/dl\\.\ \(0\)\
\-\ on\\ initial\\ noncontrast\\ head\\ ct\\ there\\ were\\ symmetric\\ regions\\ of\\ subcortical\\ hypodensity\\ in\\ the\\ parietal\\ and\\ occipital\\ lobes\\.\\ gray\\/white\\ matter\\ differentiation\\ was\\ preserved\\.\\ \ \(0\)\
\-\ mri\\ revealed\\ associated\\ t2\\ hyperintense\\ white\\ matter\\ signal\\ without\\ restricted\\ diffusion\\.\ \(0\)\
\-\ posterior\\ reversible\\ encephalopathy\\ syndrome\\ \\(pres\\)\ \(0\)\
\-\ pres\ \(6557\)\
\-\ venous\\ thrombosis\ \(55\)\
\-\ 12\\ y\\.o\\.\\ girl\\ who\\ presented\\ to\\ the\\ emergency\\ department\\ with\\ new\\ onset\\ of\\ several\\ witnessed\\ seizures\\.\\ the\\ patient\\ has\\ no\\ significant\\ past\\ medical\\ history\\.\ \(0\)\
\-\ the\\ patient\\'s\\ workup\\ for\\ end\\-stage\\ renal\\ disease\\ is\\ ongoing\\ but\\ with\\ correction\\ of\\ her\\ labs\\,\\ symptoms\\ have\\ resolved\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pres\\:\\ 0\\.11415828453951939\ \(0\)\
\-\ 12\\.0\\:\\ 0\\.06734654683675137\ \(0\)\
\-\ gray\\/white\\:\\ 0\\.06734654683675137\ \(0\)\
\-\ matter\\:\\ 0\\.06288747608225789\ \(0\)\
\-\ witnessed\\:\\ 0\\.05916459602035978\ \(0\)\
\-\ end\\-stage\\:\\ 0\\.05707914226975969\ \(0\)\
\-\ reversible\\:\\ 0\\.05349977542624469\ \(0\)\
\-\ ongoing\\:\\ 0\\.05029468429421824\ \(0\)\
\-\ hypodensity\\:\\ 0\\.049160470677355926\ \(0\)\
\-\ subcortical\\:\\ 0\\.048641126274039936\ \(0\)\
\-\ preserved\\:\\ 0\\.047236619703485375\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.047021764392974175\ \(0\)\
\-\ correction\\:\\ 0\\.04564198870319787\ \(0\)\
\-\ creatinine\\:\\ 0\\.04546051126528103\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.044936310642374085\ \(0\)\
\-\ noncontrast\\:\\ 0\\.04268245964408541\ \(0\)\
\-\ differentiation\\:\\ 0\\.04254989296191759\ \(0\)\
\-\ workup\\:\\ 0\\.04109044688009252\ \(0\)\
\-\ resolved\\:\\ 0\\.03871672513555693\ \(0\)\
\-\ serum\\:\\ 0\\.03854364992277901\ \(0\)\
\-\ occipital\\:\\ 0\\.03726359520246913\ \(0\)\
\-\ restricted\\:\\ 0\\.0367543598259825\ \(0\)\
\-\ regions\\:\\ 0\\.03654433313577634\ \(0\)\
\-\ symmetric\\:\\ 0\\.036475360170378\ \(0\)\
\-\ department\\:\\ 0\\.035812259834188426\ \(0\)\
\-\ diffusion\\:\\ 0\\.03574846576810992\ \(0\)\
\-\ seizure\\:\\ 0\\.03531369926684924\ \(0\)\
\-\ lobes\\:\\ 0\\.03519310669828935\ \(0\)\
\-\ seizures\\:\\ 0\\.0343350922192882\ \(0\)\
\-\ thrombosis\\:\\ 0\\.03428059763694435\ \(0\)\
\-\ \\-\\:\\ 0\\.034237915116044175\ \(0\)\
\-\ parietal\\:\\ 0\\.0341189948602148\ \(0\)\
\-\ hyperintense\\:\\ 0\\.033155703410309996\ \(0\)\
\-\ 12\\:\\ 0\\.032685966636656835\ \(0\)\
\-\ hypertension\\:\\ 0\\.031483935068226054\ \(0\)\
\-\ emergency\\:\\ 0\\.0302410149343951\ \(0\)\
\-\ venous\\:\\ 0\\.02898865063978625\ \(0\)\
\-\ girl\\:\\ 0\\.028078293747568202\ \(0\)\
\-\ new\\:\\ 0\\.027829794175706152\ \(0\)\
\-\ labs\\:\\ 0\\.027775458008739606\ \(0\)\
\-\ white\\:\\ 0\\.026486955258990818\ \(0\)\
\-\ initial\\:\\ 0\\.026463384516629045\ \(0\)\
\-\ several\\:\\ 0\\.025673764819835396\ \(0\)\
\-\ revealed\\:\\ 0\\.02563059710155227\ \(0\)\
\-\ past\\:\\ 0\\.025375695999499383\ \(0\)\
\-\ onset\\:\\ 0\\.025209544167524765\ \(0\)\
\-\ medical\\:\\ 0\\.02457298878566359\ \(0\)\
\-\ her\\:\\ 0\\.024013193069952667\ \(0\)\
\-\ renal\\:\\ 0\\.023995098593066064\ \(0\)\
\-\ y\\.o\\:\\ 0\\.023050275070903736\ \(0\)\
\-\ syndrome\\:\\ 0\\.02284024838069758\ \(0\)\
\-\ head\\:\\ 0\\.02265047953807379\ \(0\)\
\-\ t2\\:\\ 0\\.022603633352807028\ \(0\)\
\-\ presented\\:\\ 0\\.021769697523573918\ \(0\)\
\-\ significant\\:\\ 0\\.021475207019198347\ \(0\)\
\-\ signal\\:\\ 0\\.021056769441801668\ \(0\)\
\-\ who\\:\\ 0\\.02082213466487572\ \(0\)\
\-\ symptoms\\:\\ 0\\.019903340905590084\ \(0\)\
\-\ associated\\:\\ 0\\.0188454445038103\ \(0\)\
\-\ without\\:\\ 0\\.018803861367833272\ \(0\)\
\-\ posterior\\:\\ 0\\.0184078369037612\ \(0\)\
\-\ mri\\:\\ 0\\.01834837247583757\ \(0\)\
\-\ were\\:\\ 0\\.018133517165326365\ \(0\)\
\-\ \\'s\\:\\ 0\\.017607912321187334\ \(0\)\
\-\ have\\:\\ 0\\.017293813816496185\ \(0\)\
\-\ but\\:\\ 0\\.017032741131154557\ \(0\)\
\-\ patient\\:\\ 0\\.016011064129278278\ \(0\)\
\-\ has\\:\\ 0\\.01499719598592783\ \(0\)\
\-\ disease\\:\\ 0\\.013053621880520599\ \(0\)\
\-\ there\\:\\ 0\\.01188519211649522\ \(0\)\
\-\ ct\\:\\ 0\\.011171062181234046\ \(0\)\
\-\ history\\:\\ 0\\.011030042408477414\ \(0\)\
\-\ was\\:\\ 0\\.009236238525361559\ \(0\)\
\-\ no\\:\\ 0\\.008041534118727121\ \(0\)\
\-\ for\\:\\ 0\\.006814094847128178\ \(0\)\
\-\ on\\:\\ 0\\.006765336564162879\ \(0\)\
\-\ \\(\\:\\ 0\\.006751044170503369\ \(0\)\
\-\ \\)\\:\\ 0\\.006668576561806589\ \(0\)\
\-\ is\\:\\ 0\\.005255054003595566\ \(0\)\
\-\ the\\:\\ 0\\.005168197559014048\ \(0\)\
\-\ of\\:\\ 0\\.004355282272821997\ \(0\)\
\-\ to\\:\\ 0\\.0039912907331120205\ \(0\)\
\-\ in\\:\\ 0\\.003938291870469672\ \(0\)\
\-\ \\.\\:\\ 0\\.003317713653957596\ \(0\)\
\-\ \\,\\:\\ 0\\.002530000612311097\ \(0\)\
\-\ with\\:\\ 0\\.0021869939456054155\ \(0\)\
\-\ and\\:\\ 0\\.0016823271563758734\ \(0\)\
